The effects of piretanide and furosemide on systemic arterial blood pressure and heart rate were examined in the anesthetized dog and the effects on atrial rate and contractile force were assessed in isolated atrial muscle perfused with heparinized arterial blood from a donor dog. When piretanide was administered intravenously to intact dogs, the depressor and bradycardic responses were produced dose-dependently. There were no significant simultaneous chronotropic or inotropic changes in the isolated atrium. On the other hand, furosemide (1-3 mg/kg) did not induce significant changes in either systemic blood pressure or heart rate in the intact dog. The atrial rate and developed tension were also not affected in the isolated atrium. A potent beta-adrenoceptor blocking agent, propranolol (1mg/kg i.v.), consistently produced a significant depressor response and a profound negative chronotropic effect in the intact dogs; significant negative chronotropic and isotropic effects were also observed in the isolated atrium. When large doses of piretanide and furosemide were injected intraarterially into the sinus node artery of the isolated atrium, atropine-insensitive negative chronotropic and inotropic effects were induced dose-dependently. The potency of the negative chronotropic effect of piretanide was slightly greater than that of furosemide, but the negative inotropic effect of piretanide was slightly smaller than that of furosemide. These data indicate that piretanide has a depressor effect without significant cardiac influences. However, a high dose of piretanide has negative chronotropic and inotropic effects. These effects were not observed with the doses of furosemide (1-3mg/kg) employed in this study.
SUMMARY
The effects of piretanide and furosemide on systemic arterial blood pressure and heart rate were examined in the anesthetized dog and the effects on atrial rate and contractile force were assessed in isolated atrial muscle perfused with heparinized arterial blood from a donor dog. When piretanide was administered intravenously to intact dogs, the depressor and bradycardic responses were produced dose-dependently. There were no significant simultaneous chronotropic or inotropic changes in the isolated atrium. On the other hand, furosemide (1-3 mg/kg) did not induce significant changes in either systemic blood pressure or heart rate in the intact dog. The atrial rate and developed tension were also not affected in the isolated atrium. A potent beta-adrenoceptor blocking agent, propranolol (1mg/kg i.v.), consistently produced a significant depressor response and a profound negative chronotropic effect in the intact dogs; significant negative chronotropic and isotropic effects were also observed in the isolated atrium. When large doses of piretanide and furosemide were injected intraarterially into the sinus node artery of the isolated atrium, atropine-insensitive negative chronotropic and inotropic effects were induced dose-dependently. The potency of the negative chronotropic effect of piretanide was slightly greater than that of furosemide, but the negative inotropic effect of piretanide was slightly smaller than that of furosemide. These data indicate that piretanide has a depressor effect without significant cardiac influences. However, a high dose of piretanide has negative chronotropic and inotropic effects. These effects were not observed with the doses of furosemide (1-3mg/kg) employed in this study. 5 N NaOH (pH 9.8) and then dissolved in physiological saline. The drug solution was either injected intravenously in a volume of 0.1-1ml over a period of 10 sec into the jugular vein of the donor dog, or administered in a volume of 10 to 30ul over a period of 4 sec into the rubber tubing which conducted the blood to the arterial cannula of the isolated atrium preparation.
RESULTS
Effects of intravenous administration of piretanide to the donor dog which crosscirculated to the isolated atrium When piretanide was intravenously administered to the donor dog, a depressor response was produced dose-dependently. However, the heart rate was not modified significantly over a dose range of 1-10mg/kg. Neither chronotropic nor inotropic effects were observed in the isolated atrium. Fig.2 (A) shows a typical response to intravenous administration of piretanide to a donor dog.
When furosemide was given intravenously (1 and 3mgJkg) to the donor dog, no significant response was observed on the systemic arterial blood pressure and heart rate. By contrast, an intravenous injection of 1mg/kg of propranolol induced a marked depressor response with profound bradycardia in the donor dog and negative chronotropic and inotropic responses in the isolated atrium. Fig.2(B) shows a record during intravenous administration of 1mg/kg of propranolol to a donor dog. Data are summarized in Fig.3 .
Effects of intraarterial injection of piretanide into the sinus node artery of the isolated atrium When piretanide was injected into the cannulated sinus node artery of the isolated atrium, slight dose-dependent negative chronotropic and inotropic effects were induced. The threshold dose for inducing significant responses was approximately 1mg. The solvent induced a positive inotropic effect without changes in atrial rate. Furosemide also induced slight negative chronotropic and inotropic responses in isolated atria. Data are summarized in Fig.4 .
The piretanide-induced negative chronotropic and inotropic effects were not modified by atropine (3-10ug) in doses which completely inhibited acetylcholine(0.3ug)-induced negative chronotropic and inotropic effects in 2 experiments. Fig.5 shows records of the effects of 3 ug of atropine on Inotropic and chronotropic effects of piretanide, furosemide and solvent when given selectively into the cannulated sinus node artery of the isolated atrium (n=5). cardioactive substances in isolated and blood-perfused dog atrial preparations.13)-15) Thus, we can compare the actions of other cardioactive substances with piretanide and furosemide (Fig.6 ). It is clear that two potent loop diuretics, piretanide and furosemide, have no significant direct cardiac effects over a relatively large dose range. An extremely large dose of piretanide or furosemide has slight negative chronotropic and inotropic properties. The piretanide-induced negative chronotropic and inotropic effects were not mediated via cholinergic mechanisms, since they were not inhibited by atropine. These data indicate that therapeutic doses of piretanide have no direct cardiac action, but that extremely large doses of piretanide have a cardiac depressant property.
Furthermore, they imply that beneficial cardiac effects of piretanide may be due to secondary effects of either its potent diuretic actions or other extra-cardiac factors, such as hypotension.
